California · GLP-1 Telehealth
REMEVi serves California residents with licensed provider consultations and semaglutide or tirzepatide prescriptions. No insurance required. Free shipping to LA, San Diego, San Francisco, and everywhere in between.
Why California
Built for California's diversity, scale, and strict telehealth standards.
15.7M+ Latinos call California home (40% of state). All REMEVi care is fully bilingual — English and Spanish, every step.
California has some of the strictest telehealth standards in the country. REMEVi complies fully with California's Business & Professions Code on telemedicine.
From the agricultural Central Valley to coastal metros — REMEVi serves every California city and rural community.
Especially relevant for California's large agricultural and self-employed workforce. Transparent direct-pay pricing.
How it works
Three simple steps. Bilingual throughout.
Answer a few medical questions from your phone. English or Spanish.
A California-licensed clinician reviews your history and confirms candidacy within 24 hours.
Free, discreet shipping to any California address in 3–5 business days.
Statewide
REMEVi ships to every ZIP code in California. Major cities include:
California has the largest Hispanic population in the United States — 15.7M+ Latinos, 40% of the state — concentrated in LA, the Central Valley, the Inland Empire, and the Bay Area. REMEVi was built bilingual from day one.
Medications
Compounded semaglutide and tirzepatide from FDA-registered 503B pharmacies.
$149 first month, then $279/mo
A once-weekly GLP-1 injection, with monthly dose adjustments guided by your provider.
Learn more →$249 first month, then $379/mo*
A dual GLP-1 + GIP receptor agonist, linked to higher average weight loss.
Learn more →Pricing
Pay monthly or commit for significant savings. All-inclusive — medication, clinical review, and shipping.
One flat price at every dose. Most weight-loss programs raise your price every time your dose goes up — REMEVi never does. Visit, medication, coaching and shipping — one number. No separate membership fee. (Many programs add a $79–$149/mo membership on top of the medication price.)
Provider-managed weekly injection. The same compounded GLP-1 as the big-brand competitors — with bilingual care, no insurance, no dose upcharges.
Daily oral semaglutide. Same clinical oversight, same bilingual care — without the needle.
Dual-agonist tirzepatide. The strongest average loss in the GLP-1 category — provider-managed, bilingual care.
¹ Clinical-trial results for semaglutide (STEP-1, NEJM 2021) and tirzepatide (SURMOUNT-1, NEJM 2022) — the active medications in REMEVi protocols, not REMEVi outcomes or guarantees. Compounded preparations are not FDA-approved and have not been studied as finished products. Individual results vary.
FAQ
Yes. REMEVi fully complies with California telehealth regulations. All licensed providers hold active California medical licenses. As of July 2026, 356 clinicians in the REMEVi clinical network hold an active California license.
All of California — including Los Angeles, San Diego, San Jose, San Francisco, Fresno, Sacramento, Riverside, Oakland, Bakersfield, and beyond.
Yes. All REMEVi services are fully bilingual — available in English and Spanish.
$149 for your first month, then $279/month — or as low as $199/month on the 52-week plan. No insurance required.
Free 1-minute quiz, then a 5-minute intake if you qualify. California-licensed clinical review within 24 hours. Free shipping statewide.
See if you qualify — $149 first monthFree · no card required
